NIOX Group (LON:NIOX) Shares Up 2% – What’s Next?

Shares of NIOX Group Plc (LON:NIOX) traded up 2% during trading on Wednesday . The company traded as high as GBX 63 and last traded at GBX 62.40. 696,601 shares were traded during mid-day trading, a decline of 20% from the average session volume of 868,340 shares. The stock had previously closed at GBX 61.20.

NIOX Group Price Performance

The firm has a market cap of £266.83 million, a P/E ratio of 38.66 and a beta of 0.92. The company has a debt-to-equity ratio of 1.36, a current ratio of 3.81 and a quick ratio of 1.94. The company’s 50-day moving average is GBX 59.19 and its two-hundred day moving average is GBX 61.26.

Insider Buying and Selling at NIOX Group

In other news, insider Sarah Duncan sold 33,916 shares of the company’s stock in a transaction that occurred on Friday, May 29th. The shares were sold at an average price of GBX 59, for a total transaction of £20,010.44. Company insiders own 5.11% of the company’s stock.

NIOX Group Company Profile

NIOX Group plc is a medical technology company focused on improving the lives of millions of people suffering from respiratory health issues globally. NIOX develops and markets innovative, non-invasive diagnostic products for chronic airway diseases, primarily asthma and COPD. Its lead product, NIOX VERO®, enables the accurate measurement of fractional exhaled nitric oxide (FeNO), an established biomarker for airway inflammation, supporting better diagnosis, monitoring and management of asthma and COPD in clinical and research settings.

Headquartered in the UK and listed on the London Stock Exchange (ticker: NIOX), the company operates internationally, serving healthcare professionals in over 50 countries.